
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study has been following 11 HIV populations in Europe, North America, and Australia since 1999. Last year study researchers reported that there was about a 10% increase risk of heart attacks with protease inhibitors compared to nonnucleoside reverse transcriptase inhibitors. At this year's Conference on Retroviruses and Opportunistic Infections the researchers presented a poster comparing the cardiovascular risk of specific nucleoside drugs. This study identified 517 heart attacks in 33,000 patients over five years. Somewhat unexpectedly there was no increased risk of heart attack with AZT or Zerit despite the drugs' association with lipoatrophy, elevated lipids, and insulin resistance. More surprisingly, the researchers found that the relative risk of heart attack increased by 90% with Ziagen and 49% with Videx. Even more confusing was the fact that this elevated risk happened within the first six months of starting the drugs but did not increase with longer use. Once the drugs were stopped, the increased risks disappeared. Adjusting for other risk factors such as smoking, elevated lipids, and hypertension produced the same results. Because there appears to be no plausible mechanism to explain these results, the investigators made the unusual move to issue a position statement while the full report is being finalized. (Posters are brief 200 - 300 word summaries.) They reminded us that this is an observational report, which cannot prove causality. Only a prospective randomized trial can do that. Next they emphasized that this is a relative, not absolute, risk increase. This means that for someone with a 1% risk (such as a 20-year-old, non-smoking man) the risk increases to only 1.9%. However, in someone with a 20% risk (a 50-year-old man who smokes and has high blood pressure) the risk increase could be substantial These explanations were meant to avoid over-interpretation of the poster data and a knee-jerk reaction to take everyone off Ziagen, which would include stopping treatment with the combination pill Epzicom that contains both Ziagen and Epivir. Some experts question whether a 'channeling bias' occurred in the study, meaning that patients were selected to receive Ziagen based on other subtle criteria we haven't accounted for. And many worry that patients will stop their anti-HIV medications on their own. This concern stems in part from the results of the Strategies for Management of Antiretroviral Therapy (SMART) study that looked at treatment interruptions. That study showed those who interrupted their HIV treatment had an increased risk of heart attack due to a significant rise in inflammatory markers for plaque and clot formation that occurs during treatment breaks. The final caveat was that Viread was not part of the D:A:D study because it had not been on the market long enough when the study began to accrue a significant number of patients taking the medication. The bottom line is that HIVers should talk with their physicians about whether to stay on Ziagen and not unilaterally stop this medication. Equally important is engaging in this conversation presents an ideal time to focus on controlling the much greater heart attack risk factors of smoking, high blood pressure, elevated lipids, and diabetes. Bowers is an HIV specialist and board-certified physician in family practice, and he is a senior partner with Pacific Oaks Medical Group, one of the largest U.S. practices devoted to HIV care, in Beverly Hills, Calif.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
Plus: Featured Video
Latest Stories
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM